Rituximab in Steroid Refractory Autoimmune Hemolytic Anemia

被引：0
|
作者：
Nitin Gupta
Sanjeev Sharma
Tulika Seth
Pravas Mishra
Manoranjan Mahapatra
Suman Kumar
Rajan Kapoor
Narendra Agarwal
机构：
[1] All India Institute of Medical Sciences,Department of Hematology
来源：
The Indian Journal of Pediatrics | 2012年 / 79卷
关键词：
Autoimmune hemolytic anemia; Rituximab; Steroid refractory;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Autoimmune hemolytic anemia is rare in children and infants and steroids are the corner stone of therapy. Management of the patients with steroid refractory/dependent disease is difficult .Rituximab is being used in the treatment of a variety of autoimmune diseases including Autoimmune hemolytic anemia (AIHA),especially in adults but there is scarce data regarding the use of this agent in pediatric AIHA patients.The authors report two cases of steroid refractory AIHA, who responded to rituximab with review the literature of its use in pediatrics.
引用
收藏
页码：803 / 805
页数：2
相关论文
共 50 条
  • [21] Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia
    Fabbri, Alberto
    Gozzetti, Alessandro
    Lazzi, Stefano
    Lenoci, Mariapia
    D'Amuri, Alessandro
    Leoncini, Lorenzo
    Lauria, Francesco
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06) : 496 - 499
  • [22] B-lymphocyte reconstitution after repeated rituximab treatment in a child with steroid-dependent autoimmune hemolytic anemia
    van der Linde, Annelieke A. A.
    Schatorje, Ellen J. H.
    van der Weij, Annemieke M.
    Gemen, Eugenie F. A.
    de Vries, Esther
    PEDIATRIC REPORTS, 2011, 3 (04) : 111 - 113
  • [23] Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus
    So, Min Wook
    Koo, Bon San
    Kim, You Jae
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    MODERN RHEUMATOLOGY, 2014, 24 (05) : 855 - 857
  • [24] Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
    D'Arena, Giovanni
    Laurenti, Luca
    Capalbo, Silvana
    D'Arco, Alfonso Maria
    De Filippi, Rosaria
    Marcacci, Gianpaolo
    Di Renzo, Nicola
    Storti, Sergio
    Califano, Catello
    Vigliotti, Maria Luigia
    Tarnani, Michela
    Ferrara, Felicetto
    Pinto, Antonio
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (08) : 598 - 602
  • [25] Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia
    Barcellini, Wilma
    Zaja, Francesco
    Zaninoni, Anna
    Imperiali, Francesca Guia
    Di Bona, Eros
    Fattizzo, Bruno
    Consonni, Dario
    Cortelezzi, Agostino
    Zanella, Alberto
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (06) : 546 - 551
  • [26] Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder
    Jourdan, E
    Topart, D
    Richard, B
    Jourdan, J
    Sotto, A
    LEUKEMIA & LYMPHOMA, 2003, 44 (05) : 889 - 890
  • [27] Rituximab Treatment for Relapsed Autoimmune Hemolytic Anemia in Evans Syndrome
    Anat Galor
    Timothy O’Brien
    International Journal of Hematology, 2003, 78 : 335 - 336
  • [28] Rituximab treatment for relapsed autoimmune hemolytic anemia in Evans syndrome
    Galor, A
    O'Brien, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (04) : 335 - 336
  • [29] A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
    Piatek, Caroline, I
    Bocian, Hillel
    Algaze, Sandra
    Weitz, Ilene C.
    O'Connell, Casey
    Liebman, Howard A.
    ACTA HAEMATOLOGICA, 2020, 143 (03) : 244 - 249
  • [30] CYCLOSPORINE IN STEROID-RESISTANT AUTOIMMUNE HEMOLYTIC-ANEMIA
    DUNDAR, S
    OZDEMIR, O
    OZCEBE, O
    ACTA HAEMATOLOGICA, 1991, 86 (04) : 200 - 202
12345